The company was researching rare dermatological diseases with no approved treatments, according to its website. Timber and its subsidiary BioPharmX, a specialty dermatology pharmaceutical company, are ...
Timber Pharmaceuticals filed for chapter 11 bankruptcy protection on a day when LEO Pharma terminated a merger agreement that didn’t receive a sufficient stockholder vote at a Friday meeting. Timber ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback